Crossmark

Eczema and related atopic diseases are associated with increased symptom severity in children with autism spectrum disorder

Published Online: 2022-09-28

Authors

Jameson, C.

Boulton, K. A.

Silove, N.

Guastella, A. J. https://orcid.org/0000-0001-8178-4625
License Information

Text and Data Mining valid from 2022-09-28

Version of Record valid from 2022-09-28
More Information

Article History

Received: 4 May 2022

Revised: 8 September 2022

Accepted: 13 September 2022

First Online: 28 September 2022

Competing interests

: AG and NS declare fee for service support of pharmaceutical clinical trials for autism spectrum disorder in their clinic services (including a current and past trial with Axial Therapeutics of a gut-based therapy). These authors receive no personal financial gain from this contracted work. CJ and KB report no conflict of interests.

Document is current